期刊文献+

Bovine immunoglobulin protein isolates for the nutritional management of enteropathy 被引量:2

Bovine immunoglobulin protein isolates for the nutritional management of enteropathy
下载PDF
导出
摘要 The gastrointestinal tract is responsible for a multitude of digestive and immune functions which depend upon the balanced interaction of the intestinal microbiota, diet, gut barrier function, and mucosal immune response. Disruptions in one or more of these factors can lead to intestinal disorders or enteropathies which are characterized by intestinal inflammation, increased gut permeability, and reduced capacity to absorb nutrients. Enteropathy is frequently associated with human immunodeficiency virus(HIV) infection, inflammatory bowel disease, autoimmune enteropathy, radiation enteritis, and irritable bowel syndrome(IBS), where pathologic changes in the intestinal tract lead to abdominal discomfort, bloating, abnormal bowel function(e.g., diarrhea, urgency, constipation and malabsorption). Unfortunately, effective therapies for the management ofenteropathy and restoring intestinal health are still not available. An accumulating body of preclinical studies has demonstrated that oral administration of plasmaor serum-derived protein concentrates containing high levels of immunoglobulins can improve weight, normalize gut barrier function, and reduce the severity of enteropathy in animal models. Recent studies in humans, using serum-derived bovine immunoglobulin/protein isolate, demonstrate that such protein preparations are safe and improve symptoms, nutritional status, and various biomarkers associated with enteropathy. Benefits have been shown in patients with HIV infection or diarrhea-predominant IBS. This review summarizes preclinical and clinical studies with plasma/serum protein concentrates and describes the effects on host nutrition, intestinal function, and markers of intestinal inflammation. It supports the concept that immunoglobulin-containing protein preparations may offer a new strategy for restoring functional homeostasis in the intestinal tract of patients with enteropathy. The gastrointestinal tract is responsible for a multitude of digestive and immune functions which depend upon the balanced interaction of the intestinal microbiota, diet, gut barrier function, and mucosal immune response. Disruptions in one or more of these factors can lead to intestinal disorders or enteropathies which are characterized by intestinal inflammation, increased gut permeability, and reduced capacity to absorb nutrients. Enteropathy is frequently associated with human immunodeficiency virus (HIV) infection, inflammatory bowel disease, autoimmune enteropathy, radiation enteritis, and irritable bowel syndrome (IBS), where pathologic changes in the intestinal tract lead to abdominal discomfort, bloating, abnormal bowel function (e.g., diarrhea, urgency, constipation and malabsorption). Unfortunately, effective therapies for the management of enteropathy and restoring intestinal health are still not available. An accumulating body of preclinical studies has demonstrated that oral administration of plasma- or serum-derived protein concentrates containing high levels of immunoglobulins can improve weight, normalize gut barrier function, and reduce the severity of enteropathy in animal models. Recent studies in humans, using serum-derived bovine immunoglobulin/protein isolate, demonstrate that such protein preparations are safe and improve symptoms, nutritional status, and various biomarkers associated with enteropathy. Benefits have been shown in patients with HIV infection or diarrhea-predominant IBS. This review summarizes preclinical and clinical studies with plasma/serum protein concentrates and describes the effects on host nutrition, intestinal function, and markers of intestinal inflammation. It supports the concept that immunoglobulin-containing protein preparations may offer a new strategy for restoring functional homeostasis in the intestinal tract of patients with enteropathy.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第33期11713-11726,共14页 世界胃肠病学杂志(英文版)
关键词 IMMUNOGLOBULINS Plasma proteins Inflammation Gut barrier DIARRHEA MALABSORPTION Treatment Nutrition Immunoglobulins Plasma proteins Inflam-mation Gut
  • 相关文献

参考文献13

  • 1Magdy El-Salhy.Irritable bowel syndrome:Diagnosis and pathogenesis[J].World Journal of Gastroenterology,2012,18(37):5151-5163. 被引量:51
  • 2Epameinondas V Tsianos,Konstantinos H Katantions,Vasileios E Tsianos.Role of genetics in the diagnosis and prognosis of Crohn's disease[J].World Journal of Gastroenterology,2011,17(48):5246-5259. 被引量:8
  • 3Katri Peuhkuri,Heikki Vapaatalo,Riitta Korpela.Even low-grade inflammation impacts on small intestinal function[J].World Journal of Gastroenterology,2010,16(9):1057-1062. 被引量:9
  • 4Leena Putkonen,Chu K. Yao,Peter R. Gibson.Fructose malabsorption syndrome[J].Current Opinion in Clinical Nutrition and Metabolic Care.2013(4)
  • 5Matthew A. Ciorba.Indoleamine 2,3 dioxygenase in intestinal disease[J].Current Opinion in Gastroenterology.2013(2)
  • 6J. Matricon,M. Meleine,A. Gelot,T. Piche,M. Dapoigny,E. Muller,D. Ardid.Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome[J].Aliment Pharmacol Ther (pt).2012(11pt12)
  • 7Poonum S. Korpe,William A. Petri.Environmental enteropathy: critical implications of a poorly understood condition[J].Trends in Molecular Medicine.2012(6)
  • 8Giulia Marchetti,Alessandro Cozzi-Lepri,Esther Merlini,Giusi M. Bellistrì,Antonella Castagna,Massimo Galli,Gabriella Verucchi,Andrea Antinori,Andrea Costantini,Andrea Giacometti,Antonino di Caro,Antonella D’arminio Monforte.Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count[J].AIDS.2011(11)
  • 9Mirjana Rajili?–Stojanovi?,Elena Biagi,Hans G.H.J. Heilig,Kajsa Kajander,Riina A. Kekkonen,Sebastian Tims,Willem M. de Vos.Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome[J].Gastroenterology.2011(5)
  • 10Delphine M. Saulnier,Kevin Riehle,Toni–Ann Mistretta,Maria–Alejandra Diaz,Debasmita Mandal,Sabeen Raza,Erica M. Weidler,Xiang Qin,Cristian Coarfa,Aleksandar Milosavljevic,Joseph F. Petrosino,Sarah Highlander,Richard Gibbs,Susan V. Lynch,Robert J. Shulman,James Versalovic.Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel Syndrome[J].Gastroenterology.2011(5)

二级参考文献62

共引文献76

同被引文献13

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部